PCN90 BORTEZOMIB IS COST-EFFECTIVE FOR FIRST-LINE TREATMENT OF MULTIPLE MYELOMA IN SWEDEN
May 1, 2010, 00:00
10.1016/S1098-3015(10)72179-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)72179-3/fulltext
Title :
PCN90 BORTEZOMIB IS COST-EFFECTIVE FOR FIRST-LINE TREATMENT OF MULTIPLE MYELOMA IN SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72179-3&doi=10.1016/S1098-3015(10)72179-3
First page :
Section Title :
Open access? :
No
Section Order :
763